Camden National Bank Eli Lilly & CO Transaction History

Camden National Bank

$633 Million
Q2 2024

A detailed history of Camden National Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Camden National Bank holds 1,645 shares of LLY stock, worth $1.36 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

1,645

Previous 1,638 0.43%

Holding current value

$1.36 Million

Previous $1.27 Million 16.88%

% of portfolio

0.24%

Previous 0.23%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $5,074 - $6,363	7 Added 0.43%	1,645 $1.49 Million
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $47,376 - $63,382	-80 Reduced 4.66%	1,638 $1.27 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $21,532 - $25,384	-41 Reduced 2.33%	1,718 $1 Million
Q3 2023 Nov 03, 2023	SELL	$434.7 - $599.3 $26,082 - $35,958	-60 Reduced 3.3%	1,759 $944,000
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $12,275 - $16,414	-35 Reduced 1.89%	1,819 $853,000
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $6,523 - $7,661	-21 Reduced 1.12%	1,854 $636,000
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $14,148 - $16,485	-44 Reduced 2.29%	1,875 $686,000
Q1 2022 May 05, 2022	SELL	$234.69 - $291.66 $320,586 - $398,407	-1,366 Reduced 41.58%	1,919 $550,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $3,597 - $4,464	16 Added 0.49%	3,285 $907,000
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $239,771 - $295,072	-1,082 Reduced 24.87%	3,269 $755,000
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $39,359 - $50,911	-218 Reduced 4.77%	4,351 $999,000
Q1 2021 Aug 04, 2021	SELL	$164.32 - $212.72 $13,802 - $17,868	-84 Reduced 1.81%	4,569 $853,000
Q4 2020 Feb 01, 2021	SELL	$130.46 - $172.63 $97,845 - $129,472	-750 Reduced 13.88%	4,653 $786,000
Q3 2020 Nov 05, 2020	SELL	$146.22 - $169.13 $16,815 - $19,449	-115 Reduced 2.08%	5,403 $800,000
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $682 - $820	-5 Reduced 0.09%	5,518 $906,000
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $9,524 - $11,788	80 Added 1.47%	5,523 $766,000
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $91,523 - $113,360	856 Added 18.66%	5,443 $716,000
Q3 2019 Oct 11, 2019	SELL	$106.79 - $116.16 $69,520 - $75,620	-651 Reduced 12.43%	4,587 $513,000
Q2 2019 Aug 08, 2019	BUY	$110.79 - $129.32 $25,924 - $30,260	234 Added 4.68%	5,238 $580,000
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $2,782 - $3,275	-25 Reduced 0.5%	5,004 $649,000
Q4 2018 Feb 04, 2019	BUY	$105.9 - $118.64 $45,219 - $50,659	427 Added 9.28%	5,029 $581,000
Q3 2018 Nov 08, 2018	SELL	$85.86 - $107.31 $429 - $536	-5 Reduced 0.11%	4,602 $494,000
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $10,749 - $12,336	142 Added 3.18%	4,607 $393,000
Q3 2017 Nov 09, 2017	BUY	$77.07 - $85.54 $344,117 - $381,936	4,465	4,465 $382,000

Others Institutions Holding LLY

# of Institutions

3,912

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.95M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $788B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Camden National Bank with notifications on news.

Account

Camden National Bank Eli Lilly & CO Transaction History